Bernard Coulie - Net Worth and Insider Trading
Bernard Coulie Net Worth
The estimated net worth of Bernard Coulie is at least $13 Million dollars as of 2024-11-05. Bernard Coulie is the President and CEO of Pliant Therapeutics Inc and owns about 892,253 shares of Pliant Therapeutics Inc (PLRX) stock worth over $13 Million. Details can be seen in Bernard Coulie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bernard Coulie has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bernard Coulie
Bernard Coulie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bernard Coulie owns 2 companies in total, including Pliant Therapeutics Inc (PLRX) , and SQZ Biotechnologies Co (SQZB) .
Click here to see the complete history of Bernard Coulie’s form 4 insider trades.
Insider Ownership Summary of Bernard Coulie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | director & President and CEO |
| SQZB | SQZ Biotechnologies Co | 2021-07-01 | director |
Bernard Coulie Latest Holdings Summary
Bernard Coulie currently owns a total of 1 stock. Bernard Coulie owns 892,253 shares of Pliant Therapeutics Inc (PLRX) as of July 10, 2024, with a value of $13 Million.
Latest Holdings of Bernard Coulie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | 892,253 | 14.44 | 12,884,133 |
Holding Weightings of Bernard Coulie
Bernard Coulie Form 4 Trading Tracker
According to the SEC Form 4 filings, Bernard Coulie has made a total of 19 transactions in Pliant Therapeutics Inc (PLRX) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Pliant Therapeutics Inc is the sale of 38,710 shares on July 10, 2024, which brought Bernard Coulie around $447,488.
Insider Trading History of Bernard Coulie
- 1
Bernard Coulie Trading Performance
Bernard Coulie Ownership Network
Ownership Network List of Bernard Coulie
Ownership Network Relation of Bernard Coulie
Bernard Coulie Owned Company Details
What does Pliant Therapeutics Inc do?
Who are the key executives at Pliant Therapeutics Inc?
Bernard Coulie is the director & President and CEO of Pliant Therapeutics Inc. Other key executives at Pliant Therapeutics Inc include Chief Business Officer Hans Hull , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Keith Lamont Cummings .
Pliant Therapeutics Inc (PLRX) Insider Trades Summary
Over the past 18 months, Bernard Coulie made 3 insider transaction in Pliant Therapeutics Inc (PLRX) with a net sale of 134,581. Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 72,542 shares made by Hans Hull , a net sale of 30,386 shares made by Mike Ouimette , and a net sale of 44,935 shares made by Eric Lefebvre .
In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,907 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,907 shares.
Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pliant Therapeutics Inc Insider Transactions
Bernard Coulie Mailing Address
Above is the net worth, insider trading, and ownership report for Bernard Coulie. You might contact Bernard Coulie via mailing address: C/o Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
